Showing 881 - 900 results of 3,235 for search '"Clinical Oncology"', query time: 0.21s Refine Results
  1. 881
  2. 882

    A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy by Federico Riccardi, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli

    Published 2023-09-01
    “…Based on their beneficial mechanism of action, 15 ADCs have been approved to date by the market approval by the Food and Drug Administration (FDA), the European Medicines Agency (EMA) and/or other international governmental agencies for use in clinical oncology, and hundreds are undergoing evaluation in the preclinical and clinical phases. …”
    Get full text
    Article
  3. 883
  4. 884
  5. 885
  6. 886

    Somatometric and Index Indicators for Assessing the Physical State of Patients with Gastric Cancer by Е. A. Gorbunova, N. N. Medvedeva, G. N. Filkin

    Published 2019-01-01
    “…The research was conducted on the basis of the department of oncoabdominal surgery of Krasnoyarsk Regional Clinical Oncological Hospital named after A.I. Kryzhanovskiy in the period from 2016 to 2017. …”
    Get full text
    Article
  7. 887

    The Role of HBx Protein in Diseases Beyond the Liver by Ai L, Liu QQ, Li Y, Wang Y, Zhang HM

    Published 2023-05-01
    “…Liping Ai,1 Qing-Qing Liu,1 Yize Li,1 Yuanyuan Wang,2 Hong-Mei Zhang1 1Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China; 2Nephrology Department, Affiliated Hospital of Northwest Minzu University / Second Provincial People’s Hospital of Gansu, Lanzhou, Gansu, People’s Republic of ChinaCorrespondence: Hong-Mei Zhang, Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Changle West Road No. 127, Xi’an, Shaanxi, People’s Republic of China, Email zhm@fmmu.edu.cnAbstract: HBX gene is essential for HBV replication, evading the surveillance of the immune system by integrating its sequence into the human genome. …”
    Get full text
    Article
  8. 888

    Clinical Trials on Colorectal Cancer in South Africa by Yoshan Moodley, Samson Mashele

    Published 2023-06-01
    “…This could primarily be achieved through local capacity development in clinical oncology and research methods.…”
    Get full text
    Article
  9. 889
  10. 890
  11. 891

    Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study) by Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I

    Published 2018-11-01
    “…Hamdy A Azim,1 Ashraf Omar,2 Hesham Atef,1,† Heba Zawahry,3 Mohamed K Shaker,4 AH Kamel Abdelmaksoud,5 Mohamed EzzElarab,6 Omar Abdel-Rahman,7 Mohamed Ismail,8 Loay Kassem,1 Imam Waked9 1Department of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt; 2Department of Gastroenterology, Faculty of Medicine, Cairo University, Cairo, Egypt; 3Department of Medical Oncology, National Cancer Institute, Cairo, Egypt; 4Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; 5Department of Diagnostic and Intervention Radiology, Cairo University, Cairo, Egypt; 6National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; 7Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; 8Clinical Oncology Department, Cairo Oncology Center, Cairo, Egypt; 9Institute of Liver Disease, Menoufiya University, Menoufiya, Egypt †Dr Hesham Atef passed away on November 16, 2017, during the preparation of the manuscript Background: Phase II trials found that tegafur–uracil (UFT) is an effective drug in hepatocellular carcinoma (HCC), while preclinical data suggested that its combination with sorafenib may have a promising activity. …”
    Get full text
    Article
  12. 892
  13. 893
  14. 894
  15. 895

    Secondary Prevention of Cervical Cancer: ASCO Resource–Stratified Guideline Update by Surendra S. Shastri, Sarah Temin, Maribel Almonte, Partha Basu, Nicole G. Campos, Patty E. Gravitt, Vandana Gupta, Dorothy C. Lombe, Rául Murillo, Carolyn Nakisige, Gina Ogilvie, Leeya F. Pinder, Usha R. Poli, Youlin Qiao, Yin Ling Woo, Jose Jeronimo

    Published 2022-09-01
    “…PURPOSETo update resource-stratified, evidence-based recommendations on secondary prevention of cervical cancer globally.METHODSAmerican Society of Clinical Oncology convened a multidisciplinary, multinational Expert Panel to produce recommendations reflecting four resource-tiered settings. …”
    Get full text
    Article
  16. 896
  17. 897
  18. 898
  19. 899
  20. 900